1. Galectin-3 Involvement in Fibrotic Diseases
    Xiaosong Jiang et al, 2020, Anti-fibrotic Drug Discovery CrossRef
  2. Galectin-1 as an Emerging Mediator of Cardiovascular Inflammation: Mechanisms and Therapeutic Opportunities
    Ignacio M. Seropian et al, 2018, Mediators of Inflammation CrossRef
  3. Galectin‐3 aggravates ox‐LDL‐induced endothelial dysfunction through LOX‐1 mediated signaling pathway
    Hsiu‐Chung Ou et al, 2019, Environmental Toxicology CrossRef
  4. The Diagnostic and Therapeutic Potential of Galectin-3 in Cardiovascular Diseases
    Grażyna Sygitowicz et al, 2021, Biomolecules CrossRef
  5. Galectin-3 in Cardiovascular Diseases
    Valeria Blanda et al, 2020, International Journal of Molecular Sciences CrossRef
  6. Cardioprotective effects of galectin-3 inhibition against ischemia/reperfusion injury
    Dan Mo et al, 2019, European Journal of Pharmacology CrossRef
  7. Galectin‐3 exacerbates ox‐LDL‐mediated endothelial injury by inducing inflammation via integrin β1‐RhoA‐JNK signaling activation
    Xiumei Chen et al, 2019, Journal of Cellular Physiology CrossRef
  8. Locally delivered modified citrus pectin - a galectin-3 inhibitor shows expected anti-inflammatory and unexpected regeneration-promoting effects on repair of articular cartilage defect
    Yiyun Zhang et al, 2022, Biomaterials CrossRef
  9. Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro


    Qingqing Yin et al, 2020, Journal of Inflammation Research CrossRef
  10. Galectin-3 Is a Potential Mediator for Atherosclerosis
    Ziyu Gao et al, 2020, Journal of Immunology Research CrossRef
  11. Quercetin Attenuates Atherosclerotic Inflammation by Inhibiting Galectin‐3‐NLRP3 Signaling Pathway
    Hongxia Li et al, 2021, Molecular Nutrition & Food Research CrossRef
  12. Early Doxorubicin Myocardial Injury: Inflammatory, Oxidative Stress, and Apoptotic Role of Galectin-3
    Suhail Al-Salam et al, 2022, International Journal of Molecular Sciences CrossRef
  13. Letter to the Editor: Not all modified citrus pectins are the same: size does matter
    Isaac Eliaz, 2019, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
  14. Plasma Galectin-3 and Sonographic Measures of Carotid Atherosclerosis in the Atherosclerosis Risk in Communities Study
    Abayomi Oyenuga et al, 2019, Angiology CrossRef
  15. The interplay of galectins-1, -3, and -9 in the immune-inflammatory response underlying cardiovascular and metabolic disease
    Adel Abo Mansour et al, 2022, Cardiovascular Diabetology CrossRef
  16. Advances in Studies Using Vegetable Wastes to Obtain Pectic Substances: A Review
    Flávia Roberta Buss Marenda et al, 2019, Journal of Polymers and the Environment CrossRef
  17. In vitro fermentation properties of pectins and enzymatic-modified pectins obtained from different renewable bioresources
    Alvaro Ferreira-Lazarte et al, 2018, Carbohydrate Polymers CrossRef
  18. Potential Roles of Modified Pectin Targeting Galectin-3 against Severe Acute Respiratory Syndrome Coronavirus-2
    Frederick Odun-Ayo et al, 2021, J CrossRef
  19. Anti-inflammation effects of highly purified low-Mw RG-I pectins on LPS-activated macrophages
    Dongmei Wu et al, 2021, Bioactive Carbohydrates and Dietary Fibre CrossRef
  20. New Classification of Macrophages in Plaques: a Revolution
    Hao Deng et al, 2020, Current Atherosclerosis Reports CrossRef
  21. Value of Galectin-3 in Acute Myocardial Infarction
    Mingxing Li et al, 2020, American Journal of Cardiovascular Drugs CrossRef
  22. Pleiotropic Effects of Modified Citrus Pectin
    Isaac Eliaz et al, 2019, Nutrients CrossRef